MIXiii-BIOMED 2018: the Best of Israel's Life Science Innovations
Previous successful conferences hosted over 6,000 industry players, scientists, engineers and investors including more than 1,000 attendees from over 45 countries. As in previous years, hundreds of Israeli life science companies will present and exhibit their products, services and technologies.
Co-Chaired by Ruti Alon, Founder and CEO of Medstrada, Ora Dar, PhD, The Israel Innovation Authority and Nissim Darvish, MD, PhD, Senior Managing Director
OrbiMed, the conference will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life science. It will include the nine following tracks:
- Digital Health, IoT, and Big Data
- Next Generation Oncology Treatments
- Brain Health
- Personalized Diagnostics and Treatments
- Gene Editing and Therapies
- Nanomedicine and its Role in New Medical Therapeutics
- From Academic Research to Industry
- Cutting Edge Medical Device Technologies: Metabolic Diseases and Ophthalmology
- Novel Clinical Trial Designs and Technologies to Accelerate Drug Development
Contact
Tsipi Haitovsky, Global Media Liaison
MIXiii-BIOMED
Email: tsipihai5@gmail.com
Tel: +972-52-598-9892